EUVIMEDEUVIMED entdecken
Open Access

Repurposing antimalarials: pyrimethamine exhibits superior in vitro activity to metronidazole against Gardnerella while sparing Lactobacillus

Aliona S Rosca iD, Enesia Banda Chaponda, Thalia Beckers, Harry P De Koning, R Matthew Chico, Piet Cools

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Aliona S Rosca und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Sciences, Laboratory Bacteriology Research, Ghent University, C. Heymanslaan 10, Ghent 9000, Belgium. Hauptthemen laut MEDLINE: Pyrimethamine, Drug Repositioning, Metronidazole, Antimalarials. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, Department of Health and Social Care, Joint Global Health Trials.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bacterial vaginosis (BV) is associated with significant reproductive health risks and high recurrence rates after standard antibiotic treatment. Sulfadoxine/pyrimethamine, an antimalarial drug, demonstrated unexpected clearance of BV in clinical trials, suggesting potential antimicrobial effects. Drug repurposing, which leverages existing drugs for new therapeutic applications, offers a promising approach to address the challenges of antimicrobial resistance and high recurrence rates in BV.

Objective

To determine the in vitro activity of sulfadoxine/pyrimethamine and its components, sulfadoxine and pyrimethamine, on key species associated with BV.

Methods

Minimum inhibitory concentration (MIC) and minimum bactericidal concentration were determined for sulfadoxine/pyrimethamine (20:1 ratio), sulfadoxine, pyrimethamine, and standard-of-care antibiotics, metronidazole and clindamycin, against BV-associated species (Gardnerella spp., Fannyhessea vaginae, Prevotella bivia) and Lactobacillus crispatus (vaginal health marker). Gardnerella biofilms were also exposed to sulfadoxine/pyrimethamine, pyrimethamine, or metronidazole, and biofilm biomass and biofilm cells culturability were assessed.

Results

Sulfadoxine had no effect, while pyrimethamine inhibited all Gardnerella strains with MIC values ranging from 0.125 to 4 mg/L, lower than MICs observed for metronidazole (2–128 mg/L). Pyrimethamine also outperformed metronidazole in inhibiting biofilm mass accumulation and reducing biofilm culturable cells in 3/4 Gardnerella strains. Sulfadoxine/pyrimethamine presented lower MICs than metronidazole for 5/8 Gardnerella strains. Sulfadoxine, pyrimethamine, and sulfadoxine/pyrimethamine showed no activity against other BV-associated species or L. crispatus.

Conclusions

These findings suggest that pyrimethamine (and sulfadoxine/pyrimethamine) could be promising alternative or adjuvant therapies for BV, warranting further clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimethamineDrug RepositioningMetronidazoleAntimalarialsLactobacillusAnti-Bacterial AgentsGardnerella vaginalisHumansSulfadoxineMicrobial Sensitivity TestsFemaleDrug CombinationsVaginosis, BacterialBiofilms

Substanzen

PyrimethamineSulfadoxineMetronidazoleAntimalarialsDrug Combinationsfanasil, pyrimethamine drug combinationAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Diagnostic Sciences, Laboratory Bacteriology Research, Ghent University, C. Heymanslaan 10, Ghent 9000, Belgium.
  • Department of Biological Sciences, University of Zambia, Lusaka, Zambia.
  • School of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, 120 University Place, Glasgow G12 8TA, UK.
  • Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

ORCID-Profile: Aliona S Rosca

Förderung

  • Medical Research Council
  • Department of Health and Social Care
  • Joint Global Health Trials
  • the Medical Research Council
  • the Foreign, Commonwealth & Development Office
  • Wellcome Trust
  • Foreign, Commonwealth & Development Office

Zitieren

APA

Rosca, A. S., Chaponda, E. B., Beckers, T., De Koning, H. P., Chico, R. M., & Cools, P. (2025). Repurposing antimalarials: pyrimethamine exhibits superior in vitro activity to metronidazole against Gardnerella while sparing Lactobacillus. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf157

Vancouver

Rosca AS, Chaponda EB, Beckers T, De Koning HP, Chico RM, Cools P. Repurposing antimalarials: pyrimethamine exhibits superior in vitro activity to metronidazole against Gardnerella while sparing Lactobacillus. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf157

BibTeX
@article{Rosca2025,
  author = {Rosca, Aliona S and Chaponda, Enesia Banda and Beckers, Thalia and De Koning, Harry P and Chico, R Matthew and Cools, Piet},
  title = {Repurposing antimalarials: pyrimethamine exhibits superior in vitro activity to metronidazole against Gardnerella while sparing Lactobacillus},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf157}
}
Kostenlos starten →